{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:35:51Z","timestamp":1781825751482,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3572,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/modpathol.2012.169","type":"journal-article","created":{"date-parts":[[2012,10,19]],"date-time":"2012-10-19T07:49:34Z","timestamp":1350632974000},"page":"572-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers"],"prefix":"10.1016","volume":"26","author":[{"given":"Welmoed","family":"Reitsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian J E","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida H","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hollema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2012.169_bib1","first-page":"277","article-title":"Cancer statistics","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/modpathol.2012.169_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1038\/modpathol.2012.169_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2012.169_bib4","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"10.1038\/modpathol.2012.169_bib5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1038\/modpathol.2012.169_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Histopathologic features of genetically determined ovarian cancer","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2012.169_bib7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2012.169_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2012.169_bib9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.169_bib10","first-page":"846","article-title":"Letter commenting on \u2018Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Reitsma","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2012.169_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2012.169_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2012.169_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.mehy.2009.11.029","article-title":"The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis","volume":"74","author":"Massuger","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1038\/modpathol.2012.169_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000478-199206000-00008","article-title":"Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features","volume":"16","author":"Sherman","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.169_bib15","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","article-title":"Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation","volume":"26","author":"Ambros","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2012.169_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00000478-198203000-00002","article-title":"Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma","volume":"6","author":"Hendrickson","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.169_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2011.10.008","article-title":"Model of care for women at increased risk of breast and ovarian cancer","volume":"71","author":"De Bock","year":"2012","journal-title":"Maturitas"},{"key":"10.1038\/modpathol.2012.169_bib18","unstructured":"The Netherlands Foundation for the Detection of Hereditary Tumours (STOET). Guideline for diagnosis and prevention. Available at http:\/\/www.stoet.nl\/uploads\/richtlijnenboekje.pdf (viewed on 1 November 2011)."},{"key":"10.1038\/modpathol.2012.169_bib19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.bjc.6603015","article-title":"Surveillance of women at high risk for hereditary ovarian cancer is inefficient","volume":"94","author":"Oei","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2012.169_bib20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2012.169_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","article-title":"Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers?","volume":"124","author":"van der Velde","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2012.169_bib22","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2012.169_bib23","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2012.169_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-011-1423-4","article-title":"Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy","volume":"129","author":"Fakkert","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2012.169_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/modpathol.3800752","article-title":"Increased risk of concurrent primary malignancies in patients diagnosed with a primary malignant epithelial ovarian tumor","volume":"20","author":"van Niekerk","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2012.169_bib26","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.11372","article-title":"Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma","volume":"97","author":"Hemminki","year":"2003","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2012.169_bib27","series-title":"Statistical Methods in Cancer Research. Vol II, The Design and Analysis of Cohort Studies","article-title":"Rates and standardization","author":"Byar","year":"1987"},{"key":"10.1038\/modpathol.2012.169_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2012.169_bib29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2012.169_bib30","first-page":"1310","article-title":"The breast cancer linkage consortium","volume":"91","author":"Cancer risks in BRCA2 mutation carriers","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2012.169_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.08.004","article-title":"The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study","volume":"104","author":"Beiner","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2012.169_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2008.08.035","article-title":"Relationship between tamoxifen use and high risk endometrial cancer histologic types","volume":"112","author":"Bland","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2012.169_bib33","first-page":"1531","article-title":"BRCA germline mutations in women with uterine serous carcinoma\u2014still a debate","volume":"20","author":"Lavie","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2012.169_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","article-title":"Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?","volume":"79","author":"Goshen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2012.169_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1038\/modpathol.2012.169_bib36","first-page":"S9","article-title":"Early de novo ovarian cancer and cancer developing in benign ovarian lesions","volume":"49","author":"Scully","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1038\/modpathol.2012.169_bib37","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2012.169_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-010-0799-x","article-title":"Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1\/2 mutation carriers","volume":"124","author":"Domchek","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2012.169_bib39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2012.169_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2005.01.024","article-title":"Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer","volume":"97","author":"Meeuwissen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2012.169_bib41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00404-010-1476-3","article-title":"Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"283","author":"Rhiem","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1038\/modpathol.2012.169_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.169_bib43","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2012.169_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2012.169_bib45","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/modpathol.2012.169_bib46","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/ejhg.2009.60","article-title":"Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk","volume":"17","author":"Evans","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1038\/modpathol.2012.169_bib47","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy","volume":"19","author":"Hirst","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2012.169_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2012.169_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2012.169_bib50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/IGC.0b013e3182434a81","article-title":"concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?","volume":"22","author":"Roelofsen","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2012.169_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/gyno.1998.5267","article-title":"Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors","volume":"72","author":"Alvarado-Cabrero","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2012.169_bib52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1634\/theoncologist.1-5-326","article-title":"Prophylactic oophorectomy: reducing the US death rate from epithelial ovarian cancer. a continuing debate","volume":"1","author":"Piver","year":"1996","journal-title":"Oncologist"},{"key":"10.1038\/modpathol.2012.169_bib53","first-page":"1629","article-title":"National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons","volume":"71","author":"Averette","year":"1993","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2012.169_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2004.01.010","article-title":"Letter commenting on \u2018Pathologic finding in prophylactic oophorectomy specimens in high-risk women\u2019 (87:52-6) by Pamela Paley, et al. (fax: +31-206-685-9607)","volume":"93","author":"Mourits","year":"2004","journal-title":"Gynecol Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522202083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522202083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:55:46Z","timestamp":1760230546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522202083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S089339522202083X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2012.169","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2012.169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}